{"id":6058,"date":"2026-01-05T01:14:21","date_gmt":"2026-01-04T19:44:21","guid":{"rendered":"https:\/\/vajiramandravi.com\/upsc-exam\/?p=6058"},"modified":"2026-01-06T12:18:52","modified_gmt":"2026-01-06T06:48:52","slug":"gene-therapy","status":"publish","type":"post","link":"https:\/\/vajiramandravi.com\/upsc-exam\/gene-therapy\/","title":{"rendered":"Gene Therapy"},"content":{"rendered":"<p>Gene therapy is a rapidly advancing field in biotechnology that aims to treat genetic diseases by modifying the expression of disease-causing genes. It involves introducing healthy genes to\u00a0<strong>replace or supplement<\/strong>\u00a0faulty ones and correcting genetic abnormalities. This approach represents a shift from traditional treatments by targeting the root cause of genetic diseases instead of just managing symptoms. Recent advancements have made gene therapy a promising technology for addressing inherited disorders, with ongoing research suggesting significant potential as an innovative therapeutic tool in the future.<\/p>\r\n<h2>About Gene Therapy<\/h2>\r\n<p>It is a technique that involves<strong>\u00a0altering the genetic material<\/strong>\u00a0of cells to treat or prevent disease. It aims to introduce a normal, functional gene to compensate for the defective, disease-causing gene. The different aspects of gene therapy are discussed below:<\/p>\r\n<ul>\r\n\t<li>It employs various approaches: replacing a mutated gene with a healthy copy, inactivating a mutated gene, and introducing a new gene.<\/li>\r\n\t<li>Unlike traditional drugs, gene therapy targets the<strong>\u00a0root genetic causes inside cells.<\/strong><\/li>\r\n\t<li>Active clinical trials approach various inherited and acquired disorders. Approaches include\u00a0<strong>ex vivo modification of hematologic stem cells, T lymphocytes,<\/strong>\u00a0and other immune cells, and\u00a0<strong>in vivo delivery of genes or gene editing<\/strong>\u00a0reagents to relevant target cells.<\/li>\r\n<\/ul>\r\n<h2>Types of Gene Therapy<\/h2>\r\n<p>A\u00a0<strong>carrier\u00a0<\/strong>or\u00a0<strong>vector<\/strong>\u00a0is used to deliver the healthy gene into the patient's target cells. The two main types of therapy\u2019s are:<\/p>\r\n<ul>\r\n\t<li><strong>Somatic cell gene therapy:<\/strong>\u00a0It introduces genes into\u00a0<strong>somatic cells\u00a0<\/strong>that are<strong>\u00a0not\u00a0<\/strong>passed onto\u00a0<strong>future generations<\/strong>. It treats living persons by targeting their somatic cells.<\/li>\r\n\t<li><strong>Germline gene therapy:\u00a0<\/strong>It inserts genes into\u00a0<strong>egg or sperm cells\u00a0<\/strong>thereby modifying the genome transmitted to children and future generations. It is banned in most countries due to ethical and safety concerns.<\/li>\r\n<\/ul>\r\n<p>Gene therapies can have an autologous or allogeneic source of cells:<\/p>\r\n<ul>\r\n\t<li><strong>Autologous:<\/strong>\u00a0The patient's cells are used as a source of cells<\/li>\r\n\t<li><strong>Allogeneic<\/strong>: Cells from a donor are used as a source of cells<\/li>\r\n<\/ul>\r\n<p>Gene therapy has primarily focused on treating\u00a0<strong>monogenic disorders<\/strong>\u00a0caused by a mutation in a single gene, such as\u00a0<strong>SCID, haemophilia,\u00a0<\/strong>and\u00a0<strong>muscular dystrophy.<\/strong><\/p>\r\n<p>However, gene therapy is now expanding to target more complex multigenic diseases like<strong>\u00a0cancer, heart disease<\/strong>, and\u00a0<strong>diabetes<\/strong>\u00a0by altering the expression of multiple genes simultaneously.<\/p>\r\n<figure><img decoding=\"async\" src=\"https:\/\/vajiram-prod.s3.ap-south-1.amazonaws.com\/gene_therapy_process_cd0dca2eeb.webp\" alt=\"gene-therapy-process.webp\" \/><\/figure>\r\n<figure><img decoding=\"async\" src=\"https:\/\/vajiram-prod.s3.ap-south-1.amazonaws.com\/gene_therapy_diagram_99aa096727.webp\" alt=\"Gene Therapy Diagram\" \/><\/figure>\r\n<h2>Gene Therapy Methods and Tools<\/h2>\r\n<p>Two main approaches used are -\u00a0<strong>gene augmentation<\/strong>\u00a0to<strong>\u00a0introduce functional genes<\/strong>\u00a0and\u00a0<strong>gene inhibition\u00a0<\/strong>to<strong>\u00a0silence harmful genes<\/strong>. Advanced gene editing tools like\u00a0<strong>CRISPR-Cas9\u00a0<\/strong>and\u00a0<strong>zinc finger nucleases<\/strong>\u00a0allow precise modification of cellular DNA.<\/p>\r\n<figure>\r\n<table>\r\n<tbody>\r\n<tr>\r\n<td class=\"tb-color\"><strong>Technique<\/strong><\/td>\r\n<td class=\"tb-color\"><strong>Methodology\/Tools<\/strong><\/td>\r\n<td class=\"tb-color\"><strong>Applications<\/strong><\/td>\r\n<td class=\"tb-color\"><strong>Limitations<\/strong><\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>Viral Vectors<\/strong><\/td>\r\n<td>- Use engineered viruses like\u00a0<strong>adenovirus, retrovirus, AAV\u00a0<\/strong>to deliver therapeutic genes<\/td>\r\n<td>- Long-term gene expression, high transduction efficiency<\/td>\r\n<td>- Immunogenicity, limited DNA cargo capacity<\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>Non-viral Methods<\/strong><\/td>\r\n<td>- Physical methods like\u00a0<strong>electroporation<\/strong>\u00a0or chemical carriers like lipids and polymers deliver DNA\/RNA<\/td>\r\n<td>- Safer, non-immunogenic, unlimited cargo size<\/td>\r\n<td>- Lower delivery efficiency compared to viruses<\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>CRISPR-Cas9<\/strong><\/td>\r\n<td>- Guide RNA targets\u00a0<strong>Cas9 nuclease\u00a0<\/strong>to induce double-stranded DNA breaks enabling gene knockout or correction<\/td>\r\n<td>- Highly efficient and flexible gene editing, simple compared to other nucleases<\/td>\r\n<td>- Potential off-target effects, delivery challenges<\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>Zinc Finger Nucleases<\/strong><\/td>\r\n<td>- Artificial restriction enzymes engineered to bind and cut specific DNA sequences<\/td>\r\n<td>- Gene knockout or correction by triggering double-strand breaks<\/td>\r\n<td>- More complex engineering, lower efficiency than CRISPR<\/td>\r\n<\/tr>\r\n<tr>\r\n<td><strong>TALENs<\/strong><\/td>\r\n<td>- DNA nucleases fused to\u00a0<strong>TALE DNA<\/strong>\u00a0binding proteins cleave specific genes<\/td>\r\n<td>- Precise gene editing, similar applications as CRISPR and ZFNs<\/td>\r\n<td>- Technically challenging, lower efficiency<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<\/figure>\r\n<figure><img decoding=\"async\" src=\"https:\/\/vajiram-prod.s3.ap-south-1.amazonaws.com\/genome_editing_92648c6d16.webp\" alt=\"genome-editing.webp\" \/><\/figure>\r\n<h2>Applications of Gene Therapy<\/h2>\r\n<p>Gene therapy can potentially offer a long-term treatment benefit with just one dose for some patients. Some of the applications and the diseases targeted are:<\/p>\r\n<ul>\r\n\t<li><strong>Genetic disorders:<\/strong>\r\n<ul>\r\n\t<li>It is used to address genetic conditions like\u00a0<strong>ADA-SCID, haemophilia, muscular dystrophy, sickle cell anaemia,\u00a0<\/strong>and\u00a0<strong>retinitis pigmentosa<\/strong>. Replacing defective genes with functional copies offers treatment hope.<\/li>\r\n<\/ul>\r\n<\/li>\r\n\t<li><strong>Cancer:<\/strong>\r\n<ul>\r\n\t<li>Genes manipulating the immune system like CAR-T therapy, inhibiting tumour growth promoters, targeting cancer-specific antigens, and stopping angiogenesis are being applied against cancers.<\/li>\r\n<\/ul>\r\n<\/li>\r\n\t<li><strong>Neurodegenerative diseases:<\/strong>\r\n<ul>\r\n\t<li>Delivering nerve growth factors through gene therapy is being tried for\u00a0<strong>Alzheimer\u2019s, Parkinson\u2019s,\u00a0<\/strong>and<strong>\u00a0Amyotrophic Lateral Sclerosis(ALS)<\/strong>. Gene-edited stem cell therapy also holds promise.<\/li>\r\n<\/ul>\r\n<\/li>\r\n<\/ul>\r\n<h2>Challenges and Ethical Concerns with Gene Therapy<\/h2>\r\n<p>While gene therapy holds promise, significant challenges and ethical concerns need addressing.<\/p>\r\n<ul>\r\n\t<li><strong>Safety risks:<\/strong>\r\n<ul>\r\n\t<li>It faces challenges such as viral vector-induced immune responses, insertional mutagenesis raising cancer risk, and off-target effects with gene editing tools like CRISPR-Cas9.<\/li>\r\n\t<li>Delivery issues, vector shedding, ectopic gene expression, suboptimal levels, and pre-existing immunity also impact safety and efficacy.<\/li>\r\n<\/ul>\r\n<\/li>\r\n\t<li><strong>Ethical implications: Gene therapies also raise several ethical questions:<\/strong>\r\n<ul>\r\n\t<li><strong>Germline gene therapy<\/strong>\u00a0has the\u00a0<strong>potential for misuse<\/strong>\u00a0to edit embryos for enhancing qualities instead of curing disease leading to ethical issues.<\/li>\r\n\t<li><strong>Privacy issues<\/strong>\u00a0if genetic data is used to discriminate based on disease risks.<\/li>\r\n\t<li><strong>Justice\u00a0<\/strong>and\u00a0<strong>accessibility<\/strong>\u00a0concerns given the high costs and expertise involved.<\/li>\r\n\t<li><strong>Commercialisation\u00a0<\/strong>and\u00a0<strong>patenting<\/strong>\u00a0of gene therapies could restrict patient access.<\/li>\r\n\t<li>Potential dual use of gene editing for<strong>\u00a0biological weapons.<\/strong><\/li>\r\n\t<li><strong>Uncertainties\u00a0<\/strong>around long-term effects on future generations.<\/li>\r\n<\/ul>\r\n<\/li>\r\n<\/ul>\r\n<h2>Recent Advances in Gene Therapy<\/h2>\r\n<p>Gene therapy has made significant progress in recent years due to the development of new technologies and techniques. Here are some of the recent advances:<\/p>\r\n<ul>\r\n\t<li><strong>Gene editing tools<\/strong>\u00a0like\u00a0<strong>CRISPR-Cas9<\/strong>\u00a0and\u00a0<strong>base editors\u00a0<\/strong>have enabled more precise and efficient gene targeting. Clinical trials using CRISPR are underway for\u00a0<strong>sickle cell disease.<\/strong><\/li>\r\n\t<li><strong>Novel AAV virus capsids<\/strong>\u00a0are being engineered for improved gene delivery to tissues like the brain, eye, liver etc.<\/li>\r\n\t<li><strong>Nanoparticle delivery systems<\/strong>\u00a0such as<strong>lipid nanoparticles<\/strong>are emerging as safer non-viral vectors.<\/li>\r\n\t<li><strong>Gene regulation techniques<\/strong>\u00a0like\u00a0<strong>optogenetics<\/strong>\u00a0allow external control over gene expression using light.<\/li>\r\n\t<li><strong>High-throughput screening<\/strong>\u00a0enables the rapid discovery of gene targets and optimises delivery vectors.<\/li>\r\n<\/ul>\r\n<h2>Way Forward<\/h2>\r\n<p>Gene therapy requires more research to address challenges and risks. Progress in delivery, safety, and efficacy is promising. Diseases like\u00a0<strong>sickle cell anaemia and beta-thalassemia<\/strong>\u00a0could be cured soon. Combining with\u00a0<strong>CRISPR, TALENs, and CAR-T cells\u00a0<\/strong>expands possibilities. It signifies a new era in molecular medicine alongside precision diagnostics.<\/p>\r\n<ul>\r\n\t<li>Gene therapy also enables\u00a0<strong>regenerative approaches\u00a0<\/strong>with stem cells. Increased funding, collaboration, trials, and regulation are crucial for advancement.<\/li>\r\n\t<li><strong>Technical, ethical, and cost-related<\/strong>\u00a0issues must be tackled for real-world impact on patients.<\/li>\r\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>An overview of gene therapy &#8211; its concepts, approaches, viral and non-viral methods, ethical concerns, current applications and future scope.<\/p>\n","protected":false},"author":6,"featured_media":20094,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[239],"tags":[778,40],"class_list":{"0":"post-6058","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-quest-level-4","8":"tag-gene-therapy","9":"tag-quest"},"acf":[],"_links":{"self":[{"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/posts\/6058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/comments?post=6058"}],"version-history":[{"count":1,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/posts\/6058\/revisions"}],"predecessor-version":[{"id":19874,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/posts\/6058\/revisions\/19874"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/media\/20094"}],"wp:attachment":[{"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/media?parent=6058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/categories?post=6058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vajiramandravi.com\/upsc-exam\/wp-json\/wp\/v2\/tags?post=6058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}